M08.01
Unspecified juvenile rheumatoid arthritis, shoulder
Clinical Classification Guidelines
Medical Intelligence & Overview
Juvenile Rheumatoid Arthritis (JRA), also known as Juvenile Idiopathic Arthritis (JIA), is a condition that causes persistent inflammation in the joints of children under the age of 16. The specific subtype with shoulder involvement, classified under ICD-10 code M08.01, refers to cases where the shoulder joint is affected by this autoimmune disorder. JRA can lead to joint pain, swelling, and stiffness, affecting a child's mobility and quality of life if not properly managed. Although the exact cause isn't fully understood, JRA involves the immune system mistakenly attacking joint tissues, resulting in inflammation and potential damage over time.
Causes & Symptoms
Clinical Causes: Genetic predisposition: Family history of autoimmune diseases may increase risk. Environmental factors: Infections or environmental triggers may initiate or exacerbate the condition. Immune system dysfunction: An abnormal immune response attacks joint tissues, causing inflammation. Unknown factors: Often, the precise cause remains unidentified, making JRA a complex condition to predict or prevent.
Key Symptoms: Persistent joint swelling and tenderness in the shoulder. Stiffness that is especially noticeable in the mornings or after periods of inactivity. Reduced range of motion in the affected shoulder joint. Pain that varies in intensity and may interfere with daily activities. Possible warmth or redness around the shoulder joint. General symptoms such as fatigue, fever, or rash in some cases.
Diagnostic & Treatment
Diagnosis Path: Blood tests: To identify markers of inflammation (e.g., elevated ESR or CRP) and rule out infections or other autoimmune disorders. Imaging studies: X-rays, ultrasound, or MRI scans help visualize joint inflammation, joint damage, and rule out other causes of shoulder pain. Joint fluid analysis: Extracting and examining synovial fluid to look for signs of inflammation or infection. Monitoring symptoms over time: Since JRA can have various patterns, tracking symptom progression aids in diagnosis.
Treatment Protocols: Nonsteroidal anti-inflammatory drugs (NSAIDs): To reduce pain and inflammation. Disease-modifying antirheumatic drugs (DMARDs): Such as methotrexate, to slow disease progression and prevent joint damage. Biologic agents: Target specific parts of the immune system to decrease disease activity. Physical therapy: To improve joint flexibility, muscle strength, and functional mobility. Occupational therapy: Assists in adapting daily activities to maintain independence. Regular exercise: Gentle activities to support joint health without causing overexertion. Monitoring and management of side effects: Ongoing evaluation to ensure safety and effectiveness of treatments.
Clinical Advice & FAQs
Billing Guidance
Is M08.01 a billable ICD-10 code?
Yes, M08.01 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M08.01?
Clinical documentation must specify the nature of Unspecified juvenile rheumatoid arthritis, shoulder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference